DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression

We revealed that SNX20 was up-regulated in LGG, and its higher expression was associated with adverse clinical outcomes and poor clinical characteristics, including WHO grade, IDH mutation, 1p/19q codeletion, and primary therapy outcome. The results of the Cox regression analysis revealed that SNX20...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Jiang, Xiulin, Wang, Heping, Wang, Chunyan, Wang, Chenyang, Pan, Chenglong, Zhou, Fan, Tian, Jintao, Niu, Xiaoqun, Nie, Zhi, Chen, Wei, Huang, Xiaobin, Pu, Jun, Li, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271302/
https://www.ncbi.nlm.nih.gov/pubmed/35771139
http://dx.doi.org/10.18632/aging.204144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271302/
https://www.ncbi.nlm.nih.gov/pubmed/35771139
http://dx.doi.org/10.18632/aging.204144

Ejemplares similares